ArticleJNCI cancer spectrum2025
Impact of skilled nursing facility discharge on inpatient oncology quality outcomes.
Article in JNCI cancer spectrum, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
backgroundHospitalist comanagement of inpatient oncology patients can improve length of stay (LOS), discharge time, and readmission rates. Identifying additional clinical factors affecting LOS and readmissions will guide further oncology hospitalist practice improvement.
methodsHospitalizations on the Smilow Cancer Hospital medical oncology service with discharge to home under self-care (n = 622), home with services (n = 462), or skilled nursing facility (n = 152) from July 1, 2021, to July 31, 2022, were included. Outcomes included LOS, time of discharge, and 30-day readmission rate. Multivariable mixed linear (LOS, time of discharge) or Poisson (30-day readmission rates) models were adjusted for demographics, cancer type, severity of illness index, house staff team, and fiscal quarter and included a random intercept for patient. Analyses were 2-sided with a priori statistical significance of less than 0.05.
resultsPatients discharged to a skilled nursing facility had a longer LOS (mean = 8.25 days, 95% confidence interval [CI] = 7.13 to 9.55 days) compared with patients discharged to home under self-care (mean = 3.04 days, 95% CI = 2.76 to 3.36 days) or with services (mean = 4.48 days, 95% CI = 4.03 to 4.97 days; P < .0001). Thirty-day readmission rates for patients discharged to a skilled nursing facility (43.99%) were 10 percentage points higher than those discharged home either under self-care (32.86%) or with services (33.48%; P = .14). These differences persisted in patients regardless of severity of illness index. Of the 152 patients discharged to a skilled nursing facility, 31 (20.3%) were readmitted specifically back to the medical oncology service within 60 days with 16 (51.6%) cycling back to a skilled nursing facility, which resulted in 11 second readmissions.
conclusionFor oncology patients requiring discharge to a skilled nursing facility, mindful and upfront discharge planning may improve care quality and efficiency.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.